|
|
|
07192
|
|
|
P.I.:
|
Nadia Ewing, MD
|
(Industrial)
|
|
Title:
|
A Prospective, Non-Interventional, Multi-Center, Open Label Study to Evaluate the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Subjects with Severe Hemophilia A Receiving Prophylaxix and On Demand Treatment Regimens
|
|
|
07146
|
|
|
P.I.:
|
Nadia Ewing, MD
|
(Industrial)
|
|
Title:
|
Phase I, II/III Pharmacokinetic and Outcome Study of Inspiration's Recombinant Factor IX Product, IB 1001, in Subjects with Hemophilia B
|
| | |
|
|
06201
|
|
|
P.I.:
|
Nadia Ewing, MD
|
(Institutional)
|
|
Title:
|
Randomised Study of First TIME Immunotolerance Induction in Patients with Severe Type A Haemophilia with Inhibitor at High Risk of Failure: Comparison of Induction of Immune Tolerance with FVIII Concentrates with or without Von Willebrand Factor
|
| | |
|
|
06200
|
|
|
P.I.:
|
Nadia Ewing, MD
|
(Institutional)
|
|
Title:
|
Immune Tolerance Induction Study in Patients with Severe Type A Haemophilia with Inhibitor after Failure of a Previous Induction of Immune Tolerance with FVII Concentrates without Von Willebrand Factor Rescue
|
| | |
|
|
03082
|
|
|
P.I.:
|
Nadia Ewing, MD
|
(Institutional)
|
|
Title:
|
Hemophilia Inhibitor Genetics Study
|
|